Grupo Cooperativo Iberoamericano de Medicina Transfusional. Programa Consulta al Experto. Enfermedad hemolítica del recién nacido por incompatibilidad materno-fetal del tipo Rh. Mecanismo de acción de la profilaxis con anticuerpos policlonales y su posible reemplazo con anticuerpos monoclonales

León de González, Graciela, coord; Montaño, Ramón F; Fuenmayor, Jaheli.
Rev. argent. transfus ; 37(1): 31-39, 2011.
Artículo en Español | LILACS | ID: lil-673563

Documentos relacionados

  1. Antenatal <i>RHD</i> screening to guide antenatal anti-D immunoprophylaxis in non-immunized D- pregnant women.
  2. Receipt of RhD-positive whole blood for life-threatening bleeding in female children: A survey in alloimmunized mothers regarding minimum acceptable survival benefit relative to risk of maternal alloimmunization to anti-D.
  3. Immunological principle of development of red blood cell alloimmunization in pregnancy, hemolytic disease of the fetus and prevention of RhD alloimmunization in RhD negative women.
  4. Evaluating automated titre score as an alternative to continuous flow analysis for the prediction of passive anti-D in pregnancy.
  5. [Immuno-hematological follow up of pregnant women].
  6. Can serological methods help distinguish between prophylactic and alloimmune anti-D?
  7. Guideline No. 448: Prevention of Rh D Alloimmunization.
  8. The development of D antibodies after D-mismatched kidney transplantation in a setting of reduced immunosuppression.
  9. Routine noninvasive prenatal screening for fetal Rh D in maternal plasma-A 2-year experience from a single center in Belgium.
  10. Severe hemolytic disease of the fetus and newborn due to allo-anti-D in a patient with a partial DEL phenotype arising from the variant allele described as RHD*148+1T (RHD*01EL.31).